Hunter G. DeKoninck, Associate

Biography

Hunter DeKoninck focuses his health law practice primarily on DEA matters, including litigation and regulatory compliance under the Controlled Substances Act for clients in the pharmaceutical industry. Specifically, he specializes in areas of anti-diversion practices and suspicious order monitoring for manufacturers and distributors. He also counsels pharmacies and other practitioners on their policies and procedures for the handling of controlled substances. Relatedly, he represents clients through DEA (and other regulatory bodies) investigations associated with concerns of either diversion, record-keeping violations, or other regulatory matters.

Hunter also has significant experience counseling clients on employment agreements, including the enforcement of non-competition, non-solicitation, and confidentiality restrictions, which are critical restrictive covenants for many businesses in the health care industry. Hunter's representative experience includes:

  • Advising large wholesale drug distributors on DEA compliance, SOM policies and procedures, customer risk assessment regarding historical purchasing patterns, and other DEA-related matters
  • Representing wholesale drug distributors in the national opioid MDL
  • Defending prescribers and dispensers investigated by the DEA, states' attorneys general, and boards of pharmacy
  • Serving as national counsel for non-compete matters for a large medical device company

Legal Services

Education and Honors

  • Indiana University–Maurer School of Law (J.D., 2015)
    • Indiana Journal of Global Legal Studies, Executive Business Editor (2L Outstanding Associate of the Year, 2014)
    • International Law Society (Vice President)
    • Indiana Moot Court Competition Brief-writing Honors (2014)
  • Wake Forest University (B.A., 2012)

Bar Admissions

  • Indiana

Court Admissions

  • U.S. District Court, Northern District of Indiana
  • U.S. District Court, Southern District of Indiana